HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
James S Economou Selected Research
James S Economou Research Topics
Disease
28
Melanoma (Melanoma, Malignant)
01/2019 - 11/2002
25
Neoplasms (Cancer)
01/2019 - 02/2002
4
Experimental Melanoma
06/2012 - 06/2005
3
Liver Neoplasms (Liver Cancer)
04/2014 - 12/2003
2
Diarrhea
10/2009 - 06/2007
2
Hepatocellular Carcinoma (Hepatoma)
12/2007 - 05/2006
1
Inflammation (Inflammations)
01/2018
1
Basal Cell Carcinoma (Rodent Ulcer)
01/2012
1
Hutchinson's Melanotic Freckle (Lentigo Maligna)
01/2012
1
Actinic Keratosis
01/2012
1
Condylomata Acuminata (Genital Wart)
01/2012
1
B-Cell Lymphoma (Lymphoma, B Cell)
02/2011
1
Hypophysitis
10/2009
1
Combined Pituitary Hormone Deficiency
06/2007
1
Autoimmune Hepatitis
06/2007
1
Paraneoplastic Syndromes (Paraneoplastic Syndrome)
08/2004
Drug/Important Bio-Agent (IBA)
19
Antigens
IBA
04/2014 - 11/2002
12
Peptides (Polypeptides)
IBA
06/2018 - 02/2003
10
HLA-A*02:01 antigen
IBA
05/2013 - 03/2003
9
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
06/2018 - 02/2011
8
Epitopes
IBA
01/2012 - 03/2003
6
Vaccines
IBA
05/2014 - 11/2002
5
Neoplasm Antigens (Tumor Antigens)
IBA
01/2018 - 06/2003
5
tremelimumab
IBA
06/2011 - 06/2007
4
Cytokines
IBA
01/2019 - 07/2008
4
MART-1 Antigen
IBA
01/2018 - 09/2003
4
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
04/2014 - 12/2003
4
Monoclonal Antibodies
IBA
06/2011 - 06/2007
3
Histone Deacetylase Inhibitors
IBA
04/2014 - 11/2009
3
Proteins (Proteins, Gene)
FDA Link
02/2011 - 06/2003
2
RNA (Ribonucleic Acid)
IBA
01/2019 - 06/2003
2
Pharmaceutical Preparations
IBA
04/2014 - 01/2014
2
DNA (Deoxyribonucleic Acid)
IBA
04/2014 - 06/2003
2
Proteasome Endopeptidase Complex (Proteasome)
IBA
06/2012 - 04/2006
2
Transcription Factors (Transcription Factor)
IBA
11/2011 - 01/2009
2
Monophenol Monooxygenase (Tyrosinase)
IBA
11/2009 - 04/2008
2
Dihydrotachysterol (AT 10)
IBA
10/2009 - 05/2008
2
Biomarkers (Surrogate Marker)
IBA
01/2009 - 02/2003
1
Interleukins
IBA
01/2019
1
Protein Isoforms (Isoforms)
IBA
01/2019
1
drozitumab
IBA
04/2014
1
Vemurafenib
IBA
01/2014
1
Complementary DNA (cDNA)
IBA
05/2013
1
Transforming Growth Factor beta (TGF-beta)
IBA
06/2012
1
Interferons
IBA
06/2012
1
Toll-Like Receptor 7
IBA
01/2012
1
Imiquimod (Aldara)
FDA Link
Generic
01/2012
1
Ovalbumin
IBA
11/2011
1
LAQ824
IBA
11/2009
1
Histone Deacetylases (Histone Deacetylase)
IBA
11/2009
1
gp100 Melanoma Antigen
IBA
11/2009
1
Enzymes
IBA
01/2009
1
Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)
IBA
01/2009
1
Antibodies
IBA
05/2008
1
Melanoma-Specific Antigens
IBA
04/2008
1
CTLA-4 Antigen
IBA
06/2007
1
Proteasome Inhibitors
IBA
04/2006
1
Bortezomib (Velcade)
FDA Link
04/2006
1
Interleukin-10 (Interleukin 10)
IBA
12/2004
1
Interleukin-12 (IL 12)
IBA
11/2002
1
Autoantigens
IBA
02/2002
Therapy/Procedure
13
Immunotherapy
01/2018 - 02/2002
6
Therapeutics
01/2018 - 08/2004
3
Cell- and Tissue-Based Therapy (Cell Therapy)
05/2014 - 02/2011
3
Injections
04/2014 - 08/2004
1
Transplantation
05/2013
1
Aftercare (After-Treatment)
01/2012
1
Immunomodulation
01/2012
1
Intradermal Injections
03/2003